Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « new »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
nevi < new < newborns  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000005 (2020) Tadeusz Płusa[Options for controlling new Corona virus infection - 2019-nCoV].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000049 (2020) Yeimer Ortiz-Martínez [Colombie]Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
000108 (2020) Francesco Landi ; C. Barillaro ; A. Bellieni ; V. Brandi ; A. Carfì ; M. D Ngelo ; D. Fusco ; G. Landi ; R. Lo Monaco ; A. M. Martone ; E. Marzetti ; F. Pagano ; C. Pais ; A. Russo ; S. Salini ; M. Tosato ; A. Tummolo ; F. Benvenuto ; G. Bramato ; L. Catalano ; F. Ciciarello ; I. Martis ; S. Rocchi ; E. Rota ; A. Salerno ; M. Tritto ; A. Sgadari ; G. Zuccalà ; R. BernabeiThe New Challenge of Geriatrics: Saving Frail Older People from the SARS-CoV-2 Pandemic Infection
000152 (2020) Alfredo Sadun [États-Unis] ; Lynn GordonShould Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
000176 (2020) Giuseppe MagroSARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
000183 (2020) Ibai Los-Arcos [Espagne] ; Juan Aguilar-Company [Espagne] ; Isabel Ruiz-Camps [Espagne]Risk of infection associated with new therapies for lymphoproliferative syndromes.
000184 (2020) Maria C. Schneeweiss [États-Unis] ; Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; David Rosmarin [États-Unis] ; Joseph F. Merola [États-Unis]Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa
000233 (2020) Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
000250 (2020) Maurizio Benucci [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Luca Quartuccio [Italie]Old and new antirheumatic drugs for the treatment of COVID-19
000256 (2020) Francesco Bennardo [Italie] ; Caterina Buffone [Italie] ; Amerigo Giudice [Italie]New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws.
000257 (2020) Stefanie Glaubitz ; Rachel Zeng ; Jens SchmidtNew insights into the treatment of myositis
000258 (2020) Peter N. Taylor [Royaume-Uni] ; Lei Zhang [Royaume-Uni] ; Richard W J. Lee [Royaume-Uni] ; Ilaria Muller [Royaume-Uni] ; Daniel G. Ezra [Royaume-Uni] ; Colin M. Dayan [Royaume-Uni] ; George J. Kahaly [Allemagne] ; Marian Ludgate [Royaume-Uni]New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.
000259 (2020) Sara Pagani [Royaume-Uni] ; Mattia Bellan [Italie] ; Daniele Mauro [Royaume-Uni] ; Luigi Mario Castello [Italie] ; Gian Carlo Avanzi [Italie] ; Myles J. Lewis [Royaume-Uni] ; Pier Paolo Sainaghi [Italie] ; Costantino Pitzalis [Royaume-Uni] ; Alessandra Nerviani [Royaume-Uni]New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
000260 (2020) Ruksana HudaNew Approaches to Targeting B Cells for Myasthenia Gravis Therapy
000275 (2020) Michele Russell-Westhead [Royaume-Uni] ; Nicola O Rien [Royaume-Uni] ; Iain Goff [Royaume-Uni] ; Elizabeth Coulson [Royaume-Uni] ; Jess Pape [Royaume-Uni] ; Fraser Birrell [Royaume-Uni]Mixed methods study of a new model of care for chronic disease: co-design and sustainable implementation of group consultations into clinical practice
000326 (2020) Phillip Sommer ; Elvedin Lukovic [États-Unis] ; Eliot Fagley [États-Unis] ; Dustin R. Long [États-Unis] ; Julia B. Sobol [États-Unis] ; Katherine Heller ; Vivek K. Moitra [États-Unis] ; Ronald Pauldine [États-Unis] ; Michael F. O Onnor ; Sajid Shahul ; Mark E. Nunnally ; Avery TungInitial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago
000343 (2020) Edgar Carnero Contentti [Argentine] ; Jorge Correa [Argentine]Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
000348 (2020) Sisi Xie ; Shu Li ; Jing Tian ; Fen LiIguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
000377 (2020) Yan Zhang [République populaire de Chine] ; Ming Hu [République populaire de Chine] ; Dong Wei [République populaire de Chine] ; Hui Zhang [République populaire de Chine] ; Bao Chu [République populaire de Chine] ; Hao-Ming Xu [République populaire de Chine] ; Tao Wang [République populaire de Chine]From Severe Herpes Zoster to Rare Suid Herpesvirus Encephalitis: A New Twist of the Varicellovirus Genus Infection in Patients with Kidney Diseases
000436 (2020) Jiali Liu [République populaire de Chine] ; Xiaoliang Jin [République populaire de Chine] ; Fang Zhou [République populaire de Chine] ; Hongzhu Chen [République populaire de Chine] ; Wenjie Wang [République populaire de Chine] ; Yan Liu [République populaire de Chine] ; Guangji Wang [République populaire de Chine] ; Kun Hao [République populaire de Chine] ; Jingwei Zhang [République populaire de Chine]Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A-mediated drug hepatotoxicity.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "new" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "new" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    new
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021